|
|
Analysis of Curative Effect and Curative Effect Predictors of First-line Use of Sintilimab Combined with SOX Regimen in Patients with Advanced Gastric Cancer |
YIN Mingmei, FENG Jiangshan, ZHAO Zheng, ZHAO Weifeng, WANG Chaojie |
First-author's address: People's Hospital of Henan University, Zhengzhou 450003, China |
|
|